Van Eyk, Dunn - Proteomic and Genomic Analysis of Cardiovascular Disease - 2003 (522919), страница 70
Текст из файла (страница 70)
Spremulli. ‘The smallsubunit of the mammalian mitochondrial ribosome – Identification of the fullcomplement of ribosomal proteins present.’ Journal of Biological Chemistry 2001,276, 19363–19374.A. J. Gawron, R. S. Martin, S. M. Lunte.‘Microchip electrophoretic separation systems for biomedical and pharmaceuticalanalysis.’ European Journal of Pharmaceutical Sciences 2001, 14, 1–12.D. Figeys, D. Pinto. ‘Proteomics on achip: Promising developments.’ Electrophoresis 2001, 22, 208–216.M. A. Unger, H.-P. Chou, T. Thorsen,A.
Scherer, S. R. Quake. ‘Monolithic microfabricated valves and pumps by multilayer soft lithography.’ Science 2000, 288,113–116.J. C. McDonald et al. ‘Fabrication of microfluidic systems in poly(dimethylsiloxane).’ Electrophoresis 2000, 21, 27–40.H. Becker, K. Lowack, A. Manz. ‘Planarquartz chips with submicron channelsfor two-dimensional capillary electrophoresis applications.’ Journal of Micromechanics and Microengineering 1998, 8, 24–28.107 M. Merchant, S. R. Weinberger.
‘Re-108109110111112113114115116117cent advancements in surface-enhancedlaser desorption/ionization- time offlight-mass spectrometry.’ Electrophoresis2000, 21, 1164–1177.M. Czader et al. ‘The application of protein chip surface-enhanced laser desorption/ionization (SELDI) mass spectrometry for the identification of proteins inchronic lymphocytic leukemia.’ Blood2000, 96, 2488.C. P. Paweletz et al.
‘Rapid protein display profiling of cancer progression directly from human tissue using a proteinbiochip.’ Drug Development Research 2000,49, 34–42.S. Y. Wang, D. L. Diamond, G. M. Hass, R.Sokoloff, R. L. Vessella. ‘Identificationof prostate specific membrane antigen(PSMA) as the target of monoclonal antibody 107–1A4 by proteinchip (R); Array,surface-enhanced laser desorption/ionization (SELDI) technology.’ InternationalJournal of Cancer 2001, 92, 871–876.J. D.
Wulfkuhle et al. ‘New approachesto proteomic analysis of breast cancer.’Proteomics 2001, 1, 1205–1215.M. F. Templin et al. ‘Protein microarraytechnology.’ Trends in Biotechnology 2002,20, 160–166.A. A. Alizadeh et al. ‘Distinct types ofdiffuse large B-cell lymphoma identifiedby gene expression profiling.’ Nature2000, 403, 503–511.U. Alon et al.
‘Broad patterns of gene expression revealed by clustering analysisof tumor and normal colon tissuesprobed by oligonucleotide arrays.’ Proceedings of the National Academy ofSciences of the United States of America1999, 96, 6745–6750.A. Bhattacharjee et al.
‘Classification ofhuman lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses.’ Proceedings of theNational Academy of Sciences of the UnitedStates of America 2001, 98, 13790–13795.M. Bittner et al. ‘Molecular classification of cutaneous malignant melanomaby gene expression profiling.’ Nature2000, 406, 536–540.E. A. Clark, T. R. Golub, E.
S. Lander,R. O. Hynes. ‘Genomic analysis of metas-14.7 References118119120121122123124125126127128129tasis reveals an essential role for RhoC.’Nature 2000, 406, 532–535.S. Ramaswamy et al. ‘Multiclass cancerdiagnosis using tumor gene expressionsignatures.’ Proceedings of the NationalAcademy of Sciences of the United States ofAmerica 2001, 98, 15149–15154.G. MacBeath, S. L. Schreiber. ‘Printingproteins as microarrays for high-throughput function determination.’ Science2000, 289, 1760–1763.D.
Cahill. ‘Protein and antibody arraysand their medical applications.’ Journal ofImmunological Methods 2001, 250, 81–91.H. Zhu et al. ‘Global analysis of proteinactivities using proteome chips.’ Science2001, 293, 2101–2105.J. Madoz-Gurpide, H. Wang, D. E. Misek, F. Brichory, S. M. Hanash. ‘Proteinbased microarrays: A tool for probing theproteome of cancer cells and tissues.’Proteomics 2001, 1, 1279–1287.T. R.
Hughes et al. ‘Functional discoveryvia a compendium of expression profiles.’ Cell 2000, 102, 109–126.T. O. Joos et al. ‘A microarray enzymelinked immunosorbent assay for autoimmune diagnostics.’ Electrophoresis 2000,21, 2641–2650.B. B. Haab, M. J. Dunham, P. O. Brown.‘Protein microarrays for highly paralleldetection and quantitation of specific proteins and antibodies in complex solutions.’ Genome Biology 2001, 2, 4.1–4.13.K. Bussow et al.
‘A method for globalprotein expression and antibody screening on high-density filters of an arrayedcDNA library.’ Nucleic Acids Research1998, 26, 5007–5008.R. M. de Wildt, C. R. Mundy, B. D. Gorick, I. M. Tomlinson. ‘Antibody arraysfor high-throughput screening of antibody-antigen interactions.’ Nature Biotechnology 2000, 18, 989–994.M. L. Bulyk, E.
Gentalen, D. J. Lockhart, G. M. Church. ‘Quantifying DNAprotein interactions by double-strandedDNA arrays.’ Nature Biotechnology 1999,17, 573–577.C. A. K. Borrebaeck et al. ‘Protein chipsbased on recombinant antibody fragments: A highly sensitive approach as de-130131132133134135136137138139tected by mass spectrometry.’ Biotechniques 2001, 30, 1126–+.B. S.
Dunbar, S. M. Skinner. ‘Preparation of Monoclonal-Antibodies.’ Methodsin Enzymology 1990, 182, 670–679.E. Harlow, D. Lane, Antibodies. A laboratory manual, (Cold Spring Harbour Laboratory, New York, 1988.J. Dekruif, L. Terstappen, E. Boel, T.Logtenberg. ‘Rapid Selection of CellSubpopulation-Specific Human Monoclonal-Antibodies From a Synthetic PhageAntibody Library.’ Proceedings of the National Academy of Sciences of the UnitedStates of America 1995, 92, 3938–3942.C.
F. Barbas et al. ‘In-Vitro Evolution of aNeutralizing Human-Antibody to Human-Immunodeficiency-Virus Type-1 toEnhance Affinity and Broaden StrainCross-Reactivity.’ Proceedings of the National Academy of Sciences of the UnitedStates of America 1994, 91, 3809–3813.A. D. Griffiths et al. ‘Isolation of HighAffinity Human-Antibodies DirectlyFrom Large Synthetic Repertoires.’EMBO Journal 1994, 13, 3245–3260.J. Guzman, K.
Frei, D. Nadal. ‘In-VitroImmunization – Generation of Neutralizing Monoclonal- Antibodies to HumanInterleukin-10.’ Journal of ImmunologicalMethods 1995, 179, 265–268.G. A. Huls et al. ‘A recombinant, fullyhuman monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments.’ Nature Biotechnology 1999, 17, 276–281.J. McCafferty, A. D. Griffiths, G. Winter, D. J. Chiswell. ‘Phage Antibodies –Filamentous Phage Displaying AntibodyVariable Domains.’ Nature 1990, 348,552–554.J.
Thompson et al. ‘Affinity maturationof a high-affinity human monoclonalantibody against the third hypervariableloop of human immunodeficiency virus:Use of phage display to improve affinityand broaden strain reactivity.’ Journal ofMolecular Biology 1996, 256, 77–88.T. J. Vaughan et al.
‘Human antibodieswith sub-nanomolar affinities isolatedfrom a large non-immunized phage display library.’ Nature Biotechnology 1996,14, 309–314.25125214 Protein Chip Technology140 P. Martineau, P. Jones, G. Winter.141142143144145146147148149150151152153‘Expression of an antibody fragment athigh levels in the bacterial cytoplasm.’Journal of Molecular Biology 1998, 280,117–127.C. Miyazaki et al. ‘Changes in the specificity of antibodies by site-specific mutagenesis followed by random mutagenesis.’ Protein Engineering 1999, 12, 407–415.P. M. O’Brien, R.
Aitken, Eds., Antibody Phage Display, vol. 178 (HumanaPress Inc., Totowa, New Jersey, 2002).M. Famulok, M. Blind, G. Mayer. ‘Intramers as promising new tools in functional proteomics.’ Chemistry & Biology2001, 8, 931–939.F. Hoppe-Seyler et al. ‘Peptide aptamers:new tools to study protein interactions.’Journal of Steroid Biochemistry and Molecular Biology 2001, 78, 105–111.U. Reineke, R. Volkmer-Engert, J.Schneider-Mergener. ‘Applications ofpeptide arrays prepared by the SPOTtechnology.’ Current Opinion in Biotechnology 2001, 12, 59–64.J.
Schneider-Mergener. ‘Synthetic peptide and protein domain arrays preparedby the SPOT technology.’ Comparative andFunctional Genomics 2001, 2, 307–309.A. Lawton. ‘PROfusion: A broad-basedproteomics platform.’ British Journal ofPharmacology 2002, 135, 144P.L. C. Mattheakis, J.
M. Dias, W. J. Dower. ‘Cell-free synthesis of peptide libraries displayed on polysomes.’ Methodsin Enzymology 1996, 267, 195–207.E. N. Brody et al. ‘The use of aptamersin large arrays for molecular diagnostics.’Molecular Diagnosis 1999, 4, 381–388.J. C. Cox, A. D. Ellington. ‘Automatedselection of anti-protein aptamers.’ Bioorganic & Medicinal Chemistry 2001, 9,2525–2531.T. Hermann, D. J. Patel. ‘Biochemistryadaptive recognition by nucleic acid aptamers.’ Science 2000, 287, 820–825.A.
D. Ellington, J. W. Szostak. ‘InvitroSelection of Rna Molecules That BindSpecific Ligands.’ Nature 1990, 346, 818–822.T. S. Romig, C. Bell, D. W. Drolet. ‘Aptamer affinity chromatography: combina-154155156157158159160161162163164165torial chemistry applied to protein purification.’ Journal of Chromatography B1999, 731, 275–284.K. Haupt, K. Mosbach. ‘Plastic antibodies: developments and applications.’Trends in Biotechnology 1998, 16, 468–475.R.
J. Ansell, K. Mosbach. ‘Magnetic molecularly imprinted polymer beads fordrug radioligand binding assay.’ Analyst1998, 123, 1611–1616.L. Ye, O. Ramstrom, M. O. Mansson, K.Mosbach. ‘A new application of molecularly imprinted materials.’ Journal of Molecular Recognition 1998, 11, 75–78.S. A. Piletsky et al. ‘Substitution of antibodies and receptors with molecularlyimprinted polymers in enzyme-linkedand fluorescent assays.’ Biosensors & Bioelectronics 2001, 16, 701–707.P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
